NADPH oxidases regulate cell growth and migration in myeloid cells transformed by oncogenic tyrosine kinases

Leukemia

Volumn 25, Issue 2, 2011, Pages 281-289

  Reddy, M M ^a,b   Fernandes, M S ^a,b   Salgia, R ^c   Levine, R L ^d   Griffin, J D ^a,b   Sattler, M ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

migration; Myeloid neoplasia; NADPH oxidase; signal transduction; tyrosine kinase oncogene

Indexed keywords

MARCKS PROTEIN; PROTEIN P22; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 3; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL GROWTH; CELL MIGRATION; CELL TRANSFORMATION; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; ONCOGENE; OXYGEN CONSUMPTION; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 79751534683     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.263     Document Type: Article

References (32)

1. Walz C, Sattler M. Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML). Crit Rev Oncol Hematol 2006; 57: 145-164. (Pubitemid 43140744)
2. Levine RL, Gilliland DG. Myeloproliferative disorders. Blood 2008; 112: 2190-2198.
3. Banerji L, Sattler M. Targeting mutated tyrosine kinases in the therapy of myeloid leukaemias. Expert Opin Ther Targets 2004; 8: 221-239. (Pubitemid 38877673)
4. Sattler M, Verma S, Shrikhande G, Byrne CH, Pride YB, Winkler T et al. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem 2000; 275: 24273-24278. (Pubitemid 30626515)
5. Wernig G, Gonneville JR, Crowley BJ, Rodrigues MS, Reddy MM, Hudon HE et al. The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim protooncogenes. Blood 2008; 111: 3751-3759.
6. Sallmyr A, Fan J, Datta K, Kim KT, Grosu D, Shapiro P et al. Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML. Blood 2008; 111: 3173-3182.
7. Maulik G, Kijima T, Ma PC, Ghosh SK, Lin J, Shapiro GI et al. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer. Clin Cancer Res 2002; 8: 620-627. (Pubitemid 34193985)
8. Sattler M, Winkler T, Verma S, Byrne CH, Shrikhande G, Salgia R et al. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 1999; 93: 2928-2935. (Pubitemid 29200783)
9. Rodrigues MS, Reddy MM, Sattler M. Cell cycle regulation by oncogenic tyrosine kinases in myeloid neoplasias: from molecular redox mechanisms to health implications. Antioxid Redox Signal 2008; 10: 1813-1848.
10. Andreyev AY, Kushnareva YE, Starkov AA. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc) 2005; 70: 200-214. (Pubitemid 40512329)
11. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4: 181-189. (Pubitemid 38339084)
12. Lambeth JD, Kawahara T, Diebold B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic Biol Med 2007; 43: 319-331. (Pubitemid 46978416)
13. Ambasta RK, Kumar P, Griendling KK, Schmidt HH, Busse R, Brandes RP. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 2004; 279: 45935-45941. (Pubitemid 39491586)
14. Kawahara T, Ritsick D, Cheng G, Lambeth JD. Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1-and Nox2-dependent reactive oxygen generation. J Biol Chem 2005; 280: 31859-31869. (Pubitemid 41291936)
15. Fernandes MS, Reddy MM, Gonneville JR, Deroo SC, Podar K, Griffin JD et al. BCR-ABL promotes the frequency of mutagenic single strand annealing DNA repair. Blood 2009; 114: 1813-1819.
16. Holland PC, Clark MG, Bloxham DP, Lardy HA. Mechanism of action of the hypoglycemic agent diphenyleneiodonium. J Biol Chem 1973; 248: 6050-6056.
17. Yoshie O, Majima T, Saito H. Membrane oxidative metabolism of human eosinophilic cell line EoL-1 in response to phorbol diester and formyl peptide: synergistic augmentation by interferon-gamma and tumor necrosis factor. J Leukoc Biol 1989; 45: 10-20. (Pubitemid 19043366)
18. Walz C, Crowley BJ, Hudon HE, Gramlich JL, Neuberg DS, Podar K et al. Activated Jak2 with the V617F point mutation promotes G1/S phase transition. J Biol Chem 2006; 281: 18177-18183. (Pubitemid 44035617)
19. Kim JH, Chu SC, Gramlich JL, Pride YB, Babendreier E, Chauhan D et al. Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species. Blood 2005; 105: 1717-1723. (Pubitemid 40223695)
20. Nisimoto Y, Jackson HM, Ogawa H, Kawahara T, Lambeth JD. Constitutive NADPH-dependent electron transferase activity of the Nox4 dehydrogenase domain. Biochemistry 2010; 49: 2433-2442.
21. Nisimoto Y, Motalebi S, Han CH, Lambeth JD. The p67phox activation domain regulates electron flow from NADPH to flavin in flavocytochrome b558. J Biol Chem 1999; 274: 22999-23005.
22. Nisimoto Y, Ogawa H, Miyano K, Tamura M. Activation of the flavoprotein domain of gp91phox upon interaction with N-terminal p67phox (1-10) and the Rac complex. Biochemistry 2004; 43: 9567-9575. (Pubitemid 38955490)
23. Babior BM. NADPH oxidase. Curr Opin Immunol 2004; 16: 42-47. (Pubitemid 38198116)
24. Naughton R, Quiney C, Turner SD, Cotter TG. Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway. Leukemia 2009; 23: 1432-1440.
25. Ushio-Fukai M. Compartmentalization of Redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 2008; 11: 1289-1299.
26. Woo HA, Yim SH, Shin DH, Kang D, Yu DY, Rhee SG. Inactivation of peroxiredoxin I by phosphorylation allows localized H2O2 accumulation for cell signaling. Cell 2010; 140: 517-528.
27. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D et al. Cell transformation by the superoxide-generating oxidase Mox1. Nature 1999; 401: 79-82.
28. Mochizuki T, Furuta S, Mitsushita J, Shang WH, Ito M, Yokoo Y et al. Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene 2006; 25: 3699-3707. (Pubitemid 43980491)
29. Yamaura M, Mitsushita J, Furuta S, Kiniwa Y, Ashida A, Goto Y et al. NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression. Cancer Res 2009; 69: 2647-2654.
30. Arbuzova A, Schmitz AA, Vergeres G. Cross-talk unfolded: MARCKS proteins. Biochem J 2002; 362: 1-12. (Pubitemid 34174456)
31. Sattler M, Quinnan LR, Pride YB, Gramlich JL, Chu SC, Even GC et al. 2-Methoxyestradiol alters cell motility, migration, and adhesion. Blood 2003; 102: 289-296. (Pubitemid 36759667)
32. Thomas EK, Cancelas JA, Chae HD, Cox AD, Keller PJ, Perrotti D et al. Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease. Cancer Cell 2007; 12: 467-478. (Pubitemid 350046406)